OLGU SUNUMLARI
COVID-19 Aşılaması Sonrası Parsonage-Turner Sendromu: Klinik, Elektromiyografik Bulgular ve Rehabilitasyon Yaklaşımı
Parsonage-Turner Syndrome Following COVID-19 Vaccination: Clinical, Electromyographic Findings and Rehabilitation Approach
Received Date : 26 Jun 2024
Accepted Date : 23 Oct 2024
Available Online : 31 Oct 2024
Sefa GÜMRÜK ASLANa, Esra ÜLGEN KIRATLIOĞLUa, Nurdan KORKMAZa
aUniversity of Health Science Ankara Gaziler Physical Therapy and Rehabilitation Training and Research Hospital,
Department of Physical Medicine and Rehabilitation, Ankara, Türkiye
Doi: 10.31609/jpmrs.2024-104481 - Makale Dili: EN
Turkiye Klinikleri Journal of Physical Medicine and Rehabilitation Sciences. 2025;28(1):99-102
ÖZET
Parsonage-Turner sendromu (PTS), koronavirüs hastalığı-2019
[coronavirus disease-2019 (COVID-19)] enfeksiyonu veya aşısını takiben
nadir görülen bir durumdur. Patofizyoloji, genetik yatkınlığı olan
bireylerde brakial pleksus sinir liflerine karşı bağışıklık aracılı inflamatuar
reaksiyonu içerebilir. Bu yazıda, COVID-19 aşısını takiben PTS
klinik tablosuyla başvuran bir hastanın klinik ve elektromiyografik
özelliklerini tanımlıyoruz. Hastanın semptomları başlamadan bir hafta
önce COVID-19 aşısı uygulanmıştı. Hastaya detaylı nörolojik muayene
ve ardından sinir iletim ve elektromiyografi çalışması yapıldı. Hastanın
takip muayenesinde kol ağrısında tam iyileşme ve kas güçlerinde düzelme
sağlandı. PTS, COVID-19 aşısından sonra ortaya çıkabilir ve
akut brakial pleksopatiye işaret eden semptom ve bulguları olan hastalarda
düşünülmelidir.
Anahtar Kelimeler: Parsonage-Turner sendromu; COVID-19 aşısı; nörolojik olaylar; brakial pleksopati; elektromiyografik çalışma
ABSTRACT
Parsonage-Turner syndrome (PTS) following coronavirus
disease-2019 (COVID-19) infection or vaccination is rare. The
pathophysiology may involve an immune-mediated inflammatory reaction
against brachial plexus nerve fibers in a genetically predisposed
individual. We describe the clinical and electromyographic features of
1 patients presenting with the clinical picture of PTS following COVID-
19 vaccination. The patient had received the COVID-19 vaccine within
one week prior to the onset of symptoms. Patient underwent detailed
neurological examination followed by nerve conduction and electromyography
study. The patient attained complete resolution of the
arm pain at follow up and had recovery in strength. PTS may occur
after the COVID-19 vaccine and should be suspected in patients with
symptoms and signs suggestive of acute brachial plexopathy.
Keywords: Parsonage-Turner syndrome; COVID-19 vaccinatio; neurological events; brachial plexopathy; electromyographic studies
REFERENCES
- Feinberg JH, Radecki J. Parsonage-turner syndrome. HSS J. 2010;6:199-205. [Crossref] [PubMed] [PMC]
- van Alfen N. Clinical and pathophysiological concepts of neuralgic amyotrophy. Nat Rev Neurol. 2011;7:315-22. [Crossref] [PubMed]
- Shaikh MF, Baqai TJ, Tahir H. Acute brachial neuritis following influenza vaccination. BMJ Case Rep. 2012;2012:bcr2012007673. [Crossref] [PubMed] [PMC]
- Milner CS, Kannan K, Iyer VG, et al. Parsonage-Turner syndrome: clinical and epidemiological features from a hand surgeon's perspective. Hand (N Y). 2016;11:227-31. [Crossref] [PubMed] [PMC]
- England JD, Sumner AJ. Neuralgic amyotrophy: an increasingly diverse entity. Muscle Nerve. 1987;10:60-8. [Crossref] [PubMed]
- Magee KR, Dejong RN. Paralytic brachial neuritis. Discussion of clinical features with review of 23 cases. JAMA. 1960;174:1258-62. [Crossref] [PubMed]
- Gaskin CM, Helms CA. Parsonage-Turner syndrome: MR imaging findings and clinical information of 27 patients. Radiology. 2006;240:501-7. [Crossref] [PubMed]
- Suarez GA, Giannini C, Bosch EP, et al. Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis. Neurology. 1996;46:559-61. [Crossref] [PubMed]
- Debeer P, De Munter P, Bruyninckx F, et al. Brachial plexus neuritis following HPV vaccination. Vaccine. 2008;26:4417-9. [Crossref] [PubMed]
- Mahajan S, Zhang F, Mahajan A, et al. Parsonage Turner syndrome after COVID-19 vaccination. Muscle Nerve. 2021;64:E3-E4. [Crossref] [PubMed] [PMC]
- Diaz-Segarra N, Edmond A, Gilbert C, et al. Painless idiopathic neuralgic amyotrophy after COVID-19 vaccination: a case report. PM R. 2022;14:889-91. [Crossref] [PubMed] [PMC]
- Han CY, Tarr AM, Gewirtz AN, et al. Brachial plexopathy as a complication of COVID-19. BMJ Case Rep. 2021;14:e237459. [Crossref] [PubMed] [PMC]
- Thomas SJ, Moreira ED Jr, Kitchin N, et al; C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med. 2021;385:1761-73. [PubMed] [PMC]
- van Alfen N, van Engelen BG, Hughes RA. Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis). Cochrane Database Syst Rev. 2009;2009:CD006976. [Crossref] [PubMed] [PMC]
- Yu DK, Cho YJ, Heo DH, et al. Neuroradiologic and neurophysiologic findings of neuralgic amyotrophy. J Korean Neurosurg Soc. 2010;48:423-8. [Crossref] [PubMed] [PMC]
- Gerhard A, Raeder V, Pernice HF, et al. Neurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients. J Neurol. 2023;270:4673-7. [Crossref] [PubMed] [PMC]
- Chatterjee A, Chakravarty A. Neurological complications following COVID-19 vaccination. Curr Neurol Neurosci Rep. 2023;23:1-14. [Crossref] [PubMed] [PMC]
- Mohseni Afshar Z, Sharma A, Babazadeh A, et al. A review of the potential neurological adverse events of COVID-19 vaccines. Acta Neurol Belg. 2023;123:9-44. [Crossref] [PubMed] [PMC]